RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > The FDA Amendments Act of 2007—User Fees and More

The FDA Amendments Act of 2007—User Fees and More

Posted 01 February 2008

The Food and Drug Administration Amendments Act of 2007 (FDAAA)1 is legislation that will have far-reaching impact on regulated industry. The act, signed into law on 27 September 2007, re-committed the medical device industry to user fees and averted a financial crisis for FDA that would have significantly reduced the agency's capacity to function. The user fees will provide predictable levels of funding for FDA for the next five years.2


© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.